← Back to Search

Mode Switching Training for Color Perception Improvement

N/A
Waitlist Available
Research Sponsored by University of Minnesota
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change will be assessed over the entire study, by comparing a pre-test the day before the intevention (which lasts 5 days) to a post-test the day after the intervention.
Awards & highlights

Study Summary

This trial will study how colored lenses affect how we perceive color and how our brains process visuals. Wearers will learn to adjust to the lenses and see colors more normally.

Who is the study for?
This trial is for people with normal or corrected-to-normal vision who have little experience with tinted environments and no known visual disorders. It's not suitable for those with abnormal color vision.Check my eligibility
What is being tested?
The study tests how wearing colored lenses affects perception and brain processing, by training participants to quickly adjust to 'colored lenses mode' where colors are perceived normally despite the tint.See study design
What are the potential side effects?
There may be temporary changes in color perception when switching between normal vision and lens use. No significant side effects are expected from the colored lenses.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change will be assessed over the entire study, by comparing a pre-test the day before the intevention (which lasts 5 days) to a post-test the day after the intervention.
This trial's timeline: 3 weeks for screening, Varies for treatment, and change will be assessed over the entire study, by comparing a pre-test the day before the intevention (which lasts 5 days) to a post-test the day after the intervention. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in BOLD functional MRI activity
Change in EEG activity
Change in unique yellow settings

Trial Design

6Treatment groups
Experimental Treatment
Group I: Red RoomExperimental Treatment1 Intervention
Participants are tested in a red-illuminated room
Group II: NeuroimagingExperimental Treatment1 Intervention
Functional MRI and Electroencephelography data are acquired for multiple test colors
Group III: Gradual ChangeExperimental Treatment1 Intervention
Participants view a gradual change in tint, presented on a head-mounted display
Group IV: Dark RoomExperimental Treatment1 Intervention
Participants are tested in a completely darkened room
Group V: Color ContrastExperimental Treatment1 Intervention
Test patch is surrounded spatially by different colors
Group VI: Color AdaptationExperimental Treatment1 Intervention
Test patch is surrounded temporally (preceded) by different colors

Find a Location

Who is running the clinical trial?

University of MinnesotaLead Sponsor
1,378 Previous Clinical Trials
1,588,434 Total Patients Enrolled

Media Library

Mode Switching Training Clinical Trial Eligibility Overview. Trial Name: NCT05779228 — N/A
Chromesthesia Research Study Groups: Color Contrast, Color Adaptation, Neuroimaging, Red Room, Dark Room, Gradual Change
Chromesthesia Clinical Trial 2023: Mode Switching Training Highlights & Side Effects. Trial Name: NCT05779228 — N/A
Mode Switching Training 2023 Treatment Timeline for Medical Study. Trial Name: NCT05779228 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there an age threshold for enrollment in this trial?

"Adherent to the selection criteria of this clinical study, potential participants must be younger than 65 years old and at least 18."

Answered by AI

Do I fulfil the requirements to participate in this medical research?

"To be eligible for consideration, individuals must demonstrate appropriate behavioral qualities and fall within the 18-65 age bracket. In total, 75 people are being enrolled in this clinical trial."

Answered by AI

Are there open slots for this trial available at the moment?

"According to the clinical trial portal, this medical experiment has ceased recruiting participants as of March 18th 2023. Despite no longer taking partcipants for this particular study, 2 other trials are still welcoming new candidates."

Answered by AI
~50 spots leftby May 2029